Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04606446
Title Study of PF-07248144 in Advanced or Metastatic Solid Tumors (KAT6)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Pfizer

prostate cancer

lung non-small cell carcinoma

Her2-receptor negative breast cancer



Fulvestrant + Palbociclib + PF-07248144

Fulvestrant + PF-07248144

Letrozole + Palbociclib + PF-07248144

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.